News

Ameriprise Financial Sees Target Upgrade to $575 Amid Growth

Ameriprise Financial Sees Target Upgrade to $575 Amid Growth

Ameriprise Financial Target Adjusted Upwards

Recently, CFRA announced an increased price target for Ameriprise Financial (NYSE: AMP), raising it from $500 to $575. This adjustment reflects the company's impressive financial performance and potential for growth, making it a compelling investment option for many. The new target price is based on a valuation of Ameriprise shares at 13.7 times the firm's adjusted earnings per share (EPS) estimate for 2026, which stands at $42.10. Notably, this EPS estimate has been adjusted upwards by $1.00. Additionally, the EPS estimate for 2025 has also seen a slight increase to $38.25, reinforcing the company's robust financial outlook.

Key Financial Highlights and Stock Performance

CFRA's analyst pointed out that despite a reduction in the 2024 EPS estimate to $34.07, Ameriprise's recent Q3 earnings per share of $8.10 did not meet expectations. The earnings briefly fell short of both their anticipated $8.73 and a $8.92 consensus, largely due to a mark-to-market loss on long-duration products totaling $3.93. Nevertheless, the overall performance reflects a strong underlying business.

Long-Term Care Insurance Strategy

A significant element of the report was Ameriprise Financial's decision to maintain its long-term care insurance portfolio rather than opting for reinsuring, an approach that could mitigate potential risks. This strategy has been believed to play a critical role in today's favorable stock performance. Analysts view the current market environment as a prime opportunity for investors to increase their positions in Ameriprise Financial, highlighting its consistent revenue growth that surpasses peer performance.

Annual Revenue Growth and Financial Stability

Despite trading at a 15% discount compared to its peers, the analyst believes that the present undervaluation of Ameriprise does not reflect its strong financial metrics and growth trajectories. Year-to-date revenues have surged by 12% compared to the previous year, outpacing initial projections of a 7% to 12% growth range. Such impressive figures indicate a solid market positioning and strong operational efficiency.

Recent Q3 Earnings Insights

The latest Q3 2024 earnings call showcased Ameriprise Financial's considerable advancements, revealing a 22% upsurge in assets under management and administration, bringing the total to a remarkable $1.5 trillion. Notably, adjusted operating net revenue achieved an 11% increase, resulting in a total of $4.4 billion. The company also reported a 17% growth in earnings per share, excluding any severance costs. These accomplishments reflect a return on equity of 50.7%, improving from last year’s 49.6%, which underscores the company's profitability.

Future Plans and Growth Strategies

Looking forward, Ameriprise Financial is set to launch exciting new savings and lending products. The company aims to return an impressive 80% of its capital to shareholders in the upcoming years, with similar expectations for fiscal 2025. Despite some challenges, such as a net outflow of $2.4 billion in the Asset Management segment, the Wealth Management sector has achieved noteworthy success, logging record client assets with net inflows of $46 billion throughout the past year.

InvestingPro Analysis and Insights

Supporting CFRA's optimistic outlook, recent findings from InvestingPro elaborate on Ameriprise Financial's performance. Over the last twelve months leading to Q2 2024, Ameriprise reported an exceptional revenue of $16.96 billion, showcasing a 12.55% growth rate. This comprehensive financial health is illustrated further by a remarkable operating income margin of 35.6%, solidifying Ameriprise's superior standing compared to industry peers.

Additionally, Ameriprise has maintained a consistent track record of raising dividends for 19 consecutive years, underscoring its dedication to returning value to shareholders. With substantial liquid assets that exceed short-term obligations, Ameriprise exhibits a solid and reliable financial foundation, fostering investor confidence even amid market volatility.

Frequently Asked Questions

What is the new price target for Ameriprise Financial?

The new price target for Ameriprise Financial (NYSE: AMP) is $575, increased from the previous target of $500.

What factors led to the target price increase?

The target price increase is attributed to Ameriprise's strong financial performance, including revenue growth and a solid EPS estimate for the upcoming years.

How did Ameriprise perform in its recent Q3 earnings report?

In Q3 2024, Ameriprise reported an EPS of $8.10, with assets under management growing 22% to $1.5 trillion.

What are Ameriprise's future plans regarding capital return?

Ameriprise aims to return 80% of its capital to shareholders for both 2024 and 2025, highlighting its commitment to its investors.

What is the importance of the long-term care insurance strategy for Ameriprise?

Retaining the long-term care insurance book helps mitigate exposure and is a crucial factor in the company’s stock performance and overall strategy.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 4

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 7

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 7

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Mystique of Legends in New True Crime Podcast

Updated Category News Views 120

Unveiling Hidden Truths in True Crime en Español reVolver Podcasts and World Media Pictures Explore Iconic Myths reVolver Podcasts is excited to introduce a new podcast that takes you into the heart of legendary tales and hidden truths. True Crime en Español: Secretos de Leyenda embarks on a journey that unravels the fabric of myths and realities that have influenced...

Continue Reading
Anticipating BeiGene's Earnings: Insights for Investors

Updated Category News Views 122

Understanding BeiGene's Earnings Potential BeiGene (NASDAQ: ONC) is getting ready to unveil its quarterly earnings report. Investors are curious about the outcomes and what they might indicate for future performance. Analyst Expectations for Earnings Current estimates suggest that BeiGene will achieve an earnings per share (EPS) of $0.35. This figure reflects the...

Continue Reading
Chung-Ang University Unveils Revolutionary Air Filter Concept

Updated Category News Views 97

Chung-Ang University Introduces a Breakthrough Air Filter In an impressive leap towards better air quality, researchers from Chung-Ang University have developed a novel air filter that draws inspiration from a surprising source: nasal hair. This innovative filter, known as the particle-removing oil-coated (PRO) filter, addresses significant shortcomings found in...

Continue Reading
Altimmune's Upcoming Earnings Report: What to Expect

Updated Category News Views 103

Insights into Altimmune's Earnings Preview Altimmune (NASDAQ: ALT) is gearing up to release its latest quarterly earnings report soon. Investors are eager for insights that could shape the company's future prospects. Understanding the context around these earnings can be incredibly beneficial for those interested in the stock market. Analysts' Expectations Analysts expect...

Continue Reading
Good Springs Capital Seals $570M Fund, Strengthens Investments

Updated Category News Views 292

Good Springs Capital Successfully Closes Inaugural Fund Good Springs Capital LP, a dynamic private investment firm, recently celebrated the successful close of its inaugural fund, Good Springs Capital Fund I. This fund has amassed a remarkable total of $570 million in committed capital. With this significant achievement, Good Springs has raised its assets under management...

Continue Reading